{
    "clinical_study": {
        "@rank": "82309", 
        "acronym": "HbA2 Leuven", 
        "arm_group": {
            "arm_group_label": "HbA2 Leuven", 
            "arm_group_type": "Other", 
            "description": "Presence of HbA2 Leuven mutation, demonstrated by molecular diagnosis on blood sample."
        }, 
        "brief_summary": {
            "textblock": "The study is designed to demonstrate HbA2 Leuven mutation and to asssess its impact on\n      routine HbA1c measurements."
        }, 
        "brief_title": "HbA2 Leuven and Its Impact on HbA1c Results", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Family History HbA2 Leuven Mutation.", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Family history of HbA2 Leuven mutation.\n\n        Exclusion Criteria:\n\n          -  Any condition inhibiting simple blood withdrawal."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01909648", 
            "org_study_id": "S55709", 
            "secondary_id": "S55709"
        }, 
        "intervention": [
            {
                "arm_group_label": "HbA2 Leuven", 
                "intervention_name": "Blood withdrawal", 
                "intervention_type": "Other", 
                "other_name": "Impact of mutation on routine HbA1c measurements."
            }, 
            {
                "arm_group_label": "HbA2 Leuven", 
                "intervention_name": "Blood withdrawal", 
                "intervention_type": "Genetic", 
                "other_name": "Demonstration of HbA2 Leuven mutation"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 29, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Leuven", 
                    "country": "Belgium"
                }, 
                "name": "UZLeuven"
            }
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "1", 
        "official_title": "HbA2 Leuven and Its Impact on HbA1c Results", 
        "overall_official": [
            {
                "affiliation": "Universitaire Ziekenhuizen Leuven", 
                "last_name": "Davy MJ Kieffer, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Universitaire Ziekenhuizen Leuven", 
                "last_name": "Pieter Gillard, MD, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Universitaire Ziekenhuizen Leuven", 
                "last_name": "Koen Desmet, PharmD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Demonstration of presence/absence of HbA2 Leuven mutation", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01909648"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Demonstration of impact of HbA2 Leuven mutation on routine HbA1c measurements", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "source": "Universitaire Ziekenhuizen Leuven", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universitaire Ziekenhuizen Leuven", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}